FDA grants Priority Review status to Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple ...

Andrew Mackinnon, Executive GM, Medable, explains how the company’s recent approval in France could support the expansion of ...

In this video interview, Rachael Higgins, chief commercial officer, PicnicHealth, talks traditional research methods in clinical trials and why industry leaders remain reliant on them.

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

In this video interview, Rachael Higgins, chief commercial officer, PicnicHealth, discusses findings from the report and the industry's willingness to adopt technology.

Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve ...

COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive ...

Andrew Mackinnon, executive GM, Medable, explains how the company ensures high patient participation and data accuracy in ...

In this video interview, Cameron Breze, product manager, Inovalon, highlights current trends with decentralization and how a ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to ...

Data in and of itself can be interesting, but the true value of data lies in how you use it and the insights that come from ...